H. Lee Moffitt Cancer Center and Research Institute, Department of Diagnostic Imaging, Tampa, FL, USA.
J Breast Imaging. 2023 Jul 28;5(4):384-392. doi: 10.1093/jbi/wbad042.
Breast cancer is the second leading cause of cancer mortality in adult women in the United States. Screening mammography reduces breast cancer mortality between 22% and 48%; however, screening mammography remains underutilized. Screening mammography utilization data are available from insurance claims, electronic medical records, and patient self-report via surveys, and each data source has unique benefits and challenges. Numerous barriers exist that adversely affect the use of screening mammography in the United States. This article will review screening mammography utilization in the United States, explore factors that impact utilization, and briefly discuss strategies to improve utilization.
在美国,乳腺癌是成年女性癌症死亡的第二大主要原因。乳房 X 光筛查可降低 22%至 48%的乳腺癌死亡率;然而,乳房 X 光筛查的利用率仍然较低。来自保险索赔、电子病历和通过调查进行的患者自我报告的筛查乳房 X 光利用率数据,每种数据源都有其独特的优势和挑战。在美国,有许多障碍会对乳房 X 光筛查的使用产生不利影响。本文将回顾美国的乳房 X 光筛查利用率,探讨影响利用率的因素,并简要讨论提高利用率的策略。